Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
Genetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signa...
Saved in:
Main Authors: | Jan Mersmann (Author), Franziska Iskandar (Author), Kathrina Latsch (Author), Katharina Habeck (Author), Vera Sprunck (Author), René Zimmermann (Author), Ralf R. Schumann (Author), Kai Zacharowski (Author), Alexander Koch (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA 26a inhibits HMGB1 expression and attenuates cardiac ischemia-reperfusion injury
by: Li Yao, et al.
Published: (2016) -
Huang Qi Tong Bi Decoction Attenuates Myocardial Ischemia-Reperfusion Injury via HMGB1/TLR/NF-κB Pathway
by: Kun Liu, et al.
Published: (2019) -
Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction
by: Sun G, et al.
Published: (2021) -
Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy
by: Wenwen Wang, et al.
Published: (2019) -
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
by: Wenxuan Ren, et al.
Published: (2023)